AI-Neuro
Artificial Intelligence Applications to Neurology and Neurodegenerative Diseases
$196.84
- Hardcover
450 pages
- Release Date
26 September 2026
Summary
Artificial intelligence (AI) refers to a system that can simulate and execute the processes of human thinking and learning and make informed decisions. It can have several applications in neurology and neurodegenerative diseases which present fundamental challenges not merely in their biology but also in their modeling.
In the case of Alzheimer’s - an incredibly heterogeneous disease that is difficult to predict, diagnose, and treat - AI can improve how the disease is detected, especi…
Book Details
| ISBN-13: | 9781834546094 |
|---|---|
| ISBN-10: | 1834546095 |
| Author: | Alain L. Fymat |
| Publisher: | Tellwell Talent |
| Imprint: | Tellwell Talent |
| Format: | Hardcover |
| Number of Pages: | 450 |
| Release Date: | 26 September 2026 |
| Weight: | 1.73kg |
| Dimensions: | 33mm x 216mm x 279mm |
You Can Find This Book In
Alain L. Fymat
Dr. Alain L. Fymat
Dr. Alain L. Fymat is a medical-physical scientist and educator. He currently serves as President/CEO and Institute Professor at the International Institute of Medicine & Science in California, U.S.A. Previously, he held the positions of Executive Vice President/Chief Operating Officer and Professor at the Weil Institute of Critical Care Medicine, also located in California.
Dr. Fymat has a distinguished academic career, having served as a Professor of Radiology, Radiological Sciences, Radiation Oncology, Critical Care Medicine, and Physics at various universities in both the U.S. and Europe. His prior experience also includes a role as Deputy Director (Western Region) for the U.S. Department of Veterans Affairs (Office of Research Oversight). At the Loma Linda Veterans Affairs Medical Center, he was the Scientific Director of Radiology, Director of the Magnetic Resonance Imaging Center, and briefly Acting Chair of Radiology. Earlier in his career, he directed the Division of Biomedical and Biobehavioral Research at the University of California at Los Angeles/Drew University of Medicine and Science.
Beyond his institutional roles, Dr. Fymat has contributed significantly to scientific advisory bodies. He served as Scientific Advisor to the U.S. National Academy of Sciences, National Research Council, for its postdoctoral programs at the California Institute of Technology, and was a Member of the Advisory Group for Research & Development for the North Atlantic Treaty Organization (NATO). He is also a Health Advisor to the American Heart & Stroke Association, Coachella Valley Division, California.
A respected figure in his field, Dr. Fymat is a frequent keynote speaker and a member of scientific organizing committees for numerous international scientific and medical conferences. He has delivered extensive lectures across the U.S.A., Canada, Europe, Asia, and Africa.
Dr. Fymat’s current research is primarily focused on neurodegenerative diseases, including Alzheimer’s, Parkinson’s, dementias, epilepsy, multiple sclerosis, multiple system atrophy, Huntington’s disease, and other related conditions.
Returns
This item is eligible for free returns within 30 days of delivery. See our returns policy for further details.